Bladder Cancer - Results from #20

[How has the Paris System contributed to urine cytology? Evaluating the contribution of the Paris System to urine cytology. A comparative study of the Paris System and the Papanicolaou method in a tertiary centre]. May 13, 2022

What is the impact of dynamic contrast-enhancement sequence in the Vesical Imaging, Reporting and Data System (VI-RADS)? A subgroup analysis. May 13, 2022

National Implementation of Simulator Training Improves Transurethral Resection of Bladder Tumours in Patients. May 12, 2022

A Multicenter Retrospective Cohort Series of Muscle-invasive Bladder Cancer Patients Treated with Definitive Concurrent Chemoradiotherapy in Daily Practice. May 12, 2022

Learning Curve Analysis for Intracorporeal Robot-assisted Radical Cystectomy: Results from the EAU Robotic Urology Section Scientific Working Group. May 11, 2022

Comparative Outcomes of Primary Versus Recurrent High-risk Non-muscle-invasive and Primary Versus Secondary Muscle-invasive Bladder Cancer After Radical Cystectomy: Results from a Retrospective Multicenter Study. May 11, 2022

Prediction of the Immune Phenotypes of Bladder Cancer Patients for Precision Oncology. May 10, 2022

Quality-of-Life Outcomes in Female Patients With Ileal Conduit or Orthotopic Neobladder Urinary Diversion: 6-Month Results of a Multicenter Prospective Study. May 10, 2022

Life expectancy in metastatic urothelial bladder cancer patients according to race/ethnicity. May 9, 2022

Clinical outcomes and patterns of population-based management of urachal carcinoma of the bladder: An analysis of the National Cancer Database. May 9, 2022

Identification of Potential Biomarkers for Progression and Prognosis of Bladder Cancer by Comprehensive Bioinformatics Analysis. May 6, 2022

BCG therapy downregulates HLA-I on malignant cells to subvert antitumor immune responses in bladder cancer. May 6, 2022

ANLN Serves as an Oncogene in Bladder Urothelial Carcinoma via Activating JNK Signaling Pathway. May 5, 2022

Dual targeting of FGFR3 and ERBB3 enhances the efficacy of FGFR inhibitors in FGFR3 fusion-driven bladder cancer. May 5, 2022

Local Radiation Therapy to the Primary Bladder Tumor in Patients with Metastatic Urothelial Cancer - Expert Commentary May 4, 2022

STAG2 Protein Expression in Non-muscle-invasive Bladder Cancer: Associations with Sex, Genomic and Transcriptomic Changes, and Clinical Outcomes. May 4, 2022

Morphologic alterations post trimodal therapy in muscle-invasive urothelial carcinoma: Understanding the impact of post-treatment changes on the pathological interpretation and their potential clinical correlates. May 4, 2022

Association of Open vs Robot-Assisted Radical Cystectomy With Mortality and Perioperative Outcomes Among Patients With Bladder Cancer in Sweden. May 3, 2022

Treatment trends for muscle-invasive bladder cancer in Germany from 2006 to 2019. May 3, 2022

Neoadjuvant chemotherapy does not increase peri-operative morbidity following radical cystectomy. May 2, 2022

Page 2 of 428

email news signup